• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes

Abstract

Purpose  

Using transformations of existing quality-of-life data to estimate utilities has the potential to efficiently provide investigators
with utility information. We used within-method and across-method comparisons and estimated disutilities associated with increasing
chronic kidney disease (CKD) severity.

Methods  

In an observational cohort of veterans with diabetes (DM) and pre-existing SF-36/SF-12 responses, we used six transformation
methods (SF-12 to EQ-5D, SF-36 to HUI2, SF-12 to SF-6D, SF-36 to SF-6D, SF-36 to SF-6D (Bayesian method), and SF-12 to VR-6D)
to estimate unadjusted utilities. CKD severity was staged using glomerular filtration rate estimated from serum creatinines,
with the modification of diet in renal disease formula. We then used multivariate regression to estimate disutilities specifically
associated with CKD severity stage.

Results  

Of 67,963 patients, 22,273 patients had recent-onset DM and 45,690 patients had prevalent DM. For the recent-onset group,
the adjusted disutility associated with CKD derived from the six transformation methods ranged from 0.0029 to 0.0045 for stage
2; −0.004 to −0.0009 for early stage 3; −0.017 to −0.010 for late stage 3; −0.023 to −0.012 for stage 4; −0.078 to −0.033
for stage 5; and −0.012 to −0.001 for ESRD/dialysis.

Conclusion  

Disutility did not increase monotonically as CKD severity increased. Differences in disutilities estimated using the six different
methods were found. Both findings have implications for using such estimates in economic analyses.

  • Content Type Journal Article
  • Pages 1-12
  • DOI 10.1007/s11136-012-0139-1
  • Authors
    • Mangala Rajan, Center for Healthcare Knowledge Management, Veterans Health Administration New Jersey, East Orange, NJ, USA
    • Kuan-Chi Lai, Robert Wood Johnson Medical School – University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, USA
    • Chin-Lin Tseng, Center for Healthcare Knowledge Management, Veterans Health Administration New Jersey, East Orange, NJ, USA
    • Shirley Qian, Department of Health Policy and Management, Center for the Assessment of Pharmaceutical Practices (CAPP), Boston University School of Public Health, Boston, MA, USA
    • Alfredo Selim, Department of Health Policy and Management, Center for the Assessment of Pharmaceutical Practices (CAPP), Boston University School of Public Health, Boston, MA, USA
    • Lewis Kazis, Department of Health Policy and Management, Center for the Assessment of Pharmaceutical Practices (CAPP), Boston University School of Public Health, Boston, MA, USA
    • Leonard Pogach, Center for Healthcare Knowledge Management, Veterans Health Administration New Jersey, East Orange, NJ, USA
    • Anushua Sinha, Center for Healthcare Knowledge Management, Veterans Health Administration New Jersey, East Orange, NJ, USA
    • Journal Quality of Life Research
    • Online ISSN 1573-2649
    • Print ISSN 0962-9343
Posted in: Journal Article Abstracts on 03/09/2012 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2025 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice